Skip to content

Stroke survivors get FDA-approved daily pill shown to cut repeat risk by 26%

Photo: FOX News

Sunharbo (asundexian) is the first FDA-approved factor XIa inhibitor for secondary stroke prevention, but key limitations and risks do remain.

FOX News United States · 14 November 2026

This is an extract. The full article is on FOX News.

Read at the source

Full text, translation and AI summary — after signing in

  • The full article in your language
  • AI summary and translation from the original
  • The same account works in the Suviy app

Free.

Comments

Sign in to join the conversation. Sign in

No comments yet.